• Home
  • Licensing
  • Browse All

All Available Technologies

The current invention is a novel class of compounds that function as KOR antagonists.  Because KOR activation has been linked to depression and anxiety related disorders, this novel class of compounds may be used in the development of therapies to treat these mental disorders

Category(s):

This invention consists of a novel composition of matter as well as a process for the efficient conversion of glycerol to lactic acid.

Subcategory(s):

LED traffic signal system which melts snow and ice, preventing loss of visibility.

Subcategory(s):

The invention offers novel composition of matter to be used in treatment of a number of hormone responsive cancers.

Category(s):

Small molecule adjuvants that act as vaccine adjuvants by specifically binding to Toll-Like Receptor-8 (TLR8).

Category(s):
Subcategory(s):

A three-dimensional tumor-in-dish (TID) cell-based assay kit for cancer drug screening that closely replicates actual cellular microenvironments and, therefore, can determine which compounds to move forward for in vivo testing. 

Subcategory(s):

This technology is a process for synthesizing low-dimensional hyperthin iron disulfide (FeS2) nanostructures to be used as electrocatalysts for hydrogen production through water-splitting reactions.

Subcategory(s):

This device is an improvement on pre-existing technology. It is a nasoenteric feeding tube that is inexpensive, disposable, and designed to give the user more maneuverability and thus a better chance of successfully placing it in the small intestine.

Category(s):
Subcategory(s):

The invention is a novel adaptive aero structure based on conventional, certified aerospace materials. 

Category(s):
Subcategory(s):

The invention provides novel compounds (adjuvants) that can be used as agonists for Toll-Like Receptor 7 (TLR7).  By specifically targeting TLR7, these adjuvants elicit a type 1 interferon response which is essential in the development of antiviral responses.

Category(s):
Subcategory(s):

Pages


Events
KU Today